These novel medications , Retatrutide, represent a groundbreaking advancement in treating type 2 diabetes and potentially related disorders. They are grouped as GLP-1 pathway agonists , indicating they https://janaprjv706483.topbloghub.com/48010508/retatrutide-a-comprehensive-examination-into-incretin-agents